| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Nabriva Therapeutics plc (NASDAQ: NBRV)
NBRV Technical Analysis
2.5
| As on 9th Jun 2023 NBRV STOCK Price closed @ 1.46 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.84 & Strong Buy for SHORT-TERM with Stoploss of 0.53 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NBRVSTOCK Price
| Open | 1.50 | Change | Price | % |
| High | 1.50 | 1 Day | -0.07 | -4.58 |
| Low | 1.45 | 1 Week | -0.09 | -5.81 |
| Close | 1.46 | 1 Month | -0.12 | -7.59 |
| Volume | 9466 | 1 Year | 0.80 | 121.21 |
| 52 Week High 6.67 | 52 Week Low 0.16 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NBRV Daily Charts |
NBRV Intraday Charts |
Whats New @ Bazaartrend |
NBRV Free Analysis |
|
|
NBRV Important Levels Intraday
| RESISTANCE | 1.56 |
| RESISTANCE | 1.53 |
| RESISTANCE | 1.51 |
| RESISTANCE | 1.49 |
| SUPPORT | 1.43 |
| SUPPORT | 1.41 |
| SUPPORT | 1.39 |
| SUPPORT | 1.36 |
NBRV Forecast May 2024
| 4th UP Forecast | 1.92 |
| 3rd UP Forecast | 1.77 |
| 2nd UP Forecast | 1.68 |
| 1st UP Forecast | 1.59 |
| 1st DOWN Forecast | 1.33 |
| 2nd DOWN Forecast | 1.24 |
| 3rd DOWN Forecast | 1.15 |
| 4th DOWN Forecast | 1 |
NBRV Weekly Forecast
| 4th UP Forecast | 1.77 |
| 3rd UP Forecast | 1.67 |
| 2nd UP Forecast | 1.61 |
| 1st UP Forecast | 1.55 |
| 1st DOWN Forecast | 1.37 |
| 2nd DOWN Forecast | 1.31 |
| 3rd DOWN Forecast | 1.25 |
| 4th DOWN Forecast | 1.15 |
NBRV Forecast2024
| 4th UP Forecast | 17.45 |
| 3rd UP Forecast | 12.32 |
| 2nd UP Forecast | 9.15 |
| 1st UP Forecast | 5.98 |
| 1st DOWN Forecast | -3.06 |
| 2nd DOWN Forecast | -6.23 |
| 3rd DOWN Forecast | -9.4 |
| 4th DOWN Forecast | -14.53 |
Nabriva Therapeutics plc ( NASDAQ USA Symbol : NBRV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NBRV Business Profile
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia; and SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI). It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland. Address: 25-28 North Wall Quay, Dublin, Ireland, 1
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service